Gene · 833
Papers4,113
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 4,113
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Sarcosine dehydrogenase as an immune infiltration-associated biomarker for the prognosis of hepatocellular carcinoma. | J Cancer | 2024 | 38164283 | PubTator, text mining | PubMed |
| Mucin1 as a potential molecule for cancer immunotherapy and targeted therapy. | J Cancer | 2024 | 38164273 | PubTator, text mining | PubMed |
| Identification of common genes and pathways underlying imatinib and nilotinib treatment in CML: a Bioinformatics Study. | Nucleosides Nucleotides Nucleic Acids | 2024 | 38117080 | PubTator, text mining | PubMed |
| How to Test Human CAR T Cells in Solid Tumors, the Next Frontier of CAR T Cell Therapy. | Methods Mol Biol | 2024 | 38070118 | PubTator, text mining | PubMed |
| Rationally designed approaches to augment CAR-T therapy for solid tumor treatment. | Bioact Mater | 2024 | 38059121 | PubTator, text mining | PubMed |
| A second-generation M1-polarized CAR macrophage with antitumor efficacy. | Nat Immunol | 2024 | 38012418 | PubTator, text mining | PubMed |
| Massive parallel sequencing unveils homologous recombination deficiency in follicular dendritic cell sarcoma. | Haematologica | 2024 | 37994105 | PubTator, text mining | PubMed |
| Individualized targeted treatment in a case of a rare TFG::ROS1 fusion positive inflammatory myofibroblastic tumor (IMT). | Cancer Rep (Hoboken) | 2024 | 37950626 | PubTator, text mining | PubMed |
| Expanded Alternatives of CRISPR-Cas9 Applications in Immunotherapy of Colorectal Cancer. | Mol Diagn Ther | 2024 | 37907826 | PubTator, text mining | PubMed |
| BCMA- and CST6-specific CAR T cells lyse multiple myeloma cells and suppress murine osteolytic lesions. | J Clin Invest | 2024 | 37883186 | PubTator, text mining | PubMed |
| Bispecific CS1-BCMA CAR-T cells are clinically active in relapsed or refractory multiple myeloma. | Leukemia | 2024 | 37848634 | PubTator, text mining | PubMed |
| NLGN4X TCR transgenic T cells to treat gliomas. | Neuro Oncol | 2024 | 37715782 | PubTator, text mining | PubMed |
| Novel chimeric antigen receptor targets and constructs for acute lymphoblastic leukemia: Moving beyond CD19. | J Investig Med | 2024 | 37497999 | PubTator, text mining | PubMed |
| Novel Insights on Ferroptosis Modulation as Potential Strategy for Cancer Treatment: When Nature Kills. | Antioxid Redox Signal | 2024 | 37132605 | PubTator, text mining | PubMed |
| Using the Jurkat reporter T cell line for evaluating the functionality of novel chimeric antigen receptors. | Front Mol Med | 2023 | 39086686 | PubTator, text mining | PubMed |
| CAR designs for solid tumors: overcoming hurdles and paving the way for effective immunotherapy. | Biophys Rep | 2023 | 38516299 | PubTator, text mining | PubMed |
| Childhood leukemias in Mexico: towards implementing CAR-T cell therapy programs. | Front Oncol | 2023 | 38304036 | PubTator, text mining | PubMed |
| Treatment strategies for relapse after CAR T-cell therapy in B cell lymphoma. | Front Pediatr | 2023 | 38283399 | PubTator, text mining | PubMed |
| Beyond FOXP3: a 20-year journey unravelling human regulatory T-cell heterogeneity. | Front Immunol | 2023 | 38283365 | PubTator, text mining | PubMed |
| Oncolytic vaccinia virus and cancer immunotherapy. | Front Immunol | 2023 | 38283361 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/833/papers?page=11